English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech BioTech (Sci&Research)
Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can Tap the Region
Jul 14, 2020 06:00 HKT
Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award
Jul 09, 2020 00:30 HKT
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin
Jul 01, 2020 19:00 HKT
Captiva Verde Land Corp Announces Solargram Farms Corporation Receives Health Canada Standard Cultivation Cannabis License for Renauds Mills, New Brunswick
Jun 30, 2020 05:00 HKT
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance
Jun 24, 2020 14:00 HKT
New EIU report shows lack of integrated follow up care can increase risk of subsequent heart attack or stroke in APAC economies
Jun 24, 2020 04:30 HKT
Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin's Phase III Monotherapy Trial
Jun 18, 2020 18:30 HKT
Novotech Partners with South Korea's Pusan National University Hospital
Jun 18, 2020 11:00 HKT
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal
Jun 17, 2020 18:00 HKT
VerifyMe and Gohar Group's Techind Form Strategic Relationship to Address Product Authentication and Brand Protection in India's Large and Emerging Pharmaceutical Market
Jun 15, 2020 21:00 HKT
Agilex Biolabs Encourages Biotechs to Move Delayed Trials to Australia at BIO Digital 2020
Jun 11, 2020 05:00 HKT
SinoMab Announces Clinical Results on its First-in-target SM03 at EULAR 2020 Congress
Jun 10, 2020 07:52 HKT
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020
Jun 09, 2020 20:00 HKT
Joonghun Pharmaceutical of Korea Targets Overseas Markets for Coronavirus Diagnostic Kits
Jun 09, 2020 11:00 HKT
Blockchain Holdings Ltd. subsidiary TraceSafe and Toronto Wolfpack Sign Contract for Wearable Technology to Safely Reopen Lamport Stadium
Jun 02, 2020 00:00 HKT
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
Jun 01, 2020 13:00 HKT
After Scientific Breakthrough: Digid Seeks FDA Approval for Its Rapid Corona Antigen Test
May 30, 2020 10:00 HKT
Sino Biopharmaceutical Announces 2020 First Quarterly Results
May 28, 2020 19:59 HKT
Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences' COVID-19 Neutralizing Antibodies
May 27, 2020 10:41 HKT
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration
May 26, 2020 17:16 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: